Company Description

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States.

It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.

The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.

GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

GlucoTrack, Inc.

Country	United States
Founded	2001
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	11
CEO	Paul Goode

Contact Details

Address: 301 Route 17 North, Suite 800 Rutherford, New Jersey 07070 United States
Phone	201 842 7715
Website	glucotrack.com

Stock Details

Ticker Symbol	GCTK
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001506983
CUSIP Number	45824Q507
ISIN Number	US45824Q5071
Employer ID	98-0668934
SIC Code	3841

Key Executives

Name	Position
Paul V. Goode Ph.D.	Chief Executive Officer, President and Director
Avner Gal MBA, MSc.EE	Co-Founder, Chairman Emeritus, Consultant and Member of Scientific and Clinical Advisory Board
David Malka BA	Co-Founder
Peter C. Wulff	Chief Financial Officer
Vincent Wong	Vice President of Operations
Mark Tapsak Ph.D.	Chief Scientific Officer
Drinda Benjamin	Vice President of Marketing

Latest SEC Filings

Date	Type	Title
Apr 28, 2025	ARS	Filing
Apr 28, 2025	DEF 14A	Other definitive proxy statements
Apr 18, 2025	PRE 14A	Other preliminary proxy statements
Apr 16, 2025	8-K	Current Report
Apr 4, 2025	8-K	Current Report
Apr 3, 2025	8-K	Current Report
Mar 31, 2025	10-K	Annual Report
Mar 31, 2025	8-K	Current Report
Mar 19, 2025	8-K	Current Report
Mar 13, 2025	8-K	Current Report

View All SEC Filings